Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 8102170, 5 pages
https://doi.org/10.1155/2017/8102170
Research Article

Mouse Thyroid Gland Changes in Aging: Implication of Galectin-3 and Sphingomyelinase

1Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
2Division of Anatomic Pathology and Histology, Department of Experimental Medicine, School of Medicine and Surgery, University of Perugia, Perugia, Italy
3Department of Medica Area, University of Udine, P.le M. Kolbe 4, 33100 Udine, Italy

Correspondence should be addressed to Elisabetta Albi; ti.gpinu@ibla.attebasile

Received 29 August 2017; Accepted 12 November 2017; Published 11 December 2017

Academic Editor: Fabiola Olivieri

Copyright © 2017 Giovanna Traina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. R. Vasta, “Galectins as pattern recognition receptors: structure, function, and evolution,” Advances in Experimental Medicine and Biology, vol. 946, pp. 21–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Nio-Kobayashi, “Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease,” Anatomical Science International, vol. 92, no. 1, pp. 25–36, 2017. View at Publisher · View at Google Scholar
  3. K. C. Haudek, K. J. Spronk, P. G. Voss, R. J. Patterson, J. L. Wang, and E. J. Arnoys, “Dynamics of galectin-3 in the nucleus and cytoplasm,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1800, no. 2, pp. 181–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Díaz-Alvarez and E. Ortega, “The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens,” Mediators of Inflammation, vol. 2017, Article ID 9247574, 10 pages, 2017. View at Publisher · View at Google Scholar
  5. S. Dabelic, R. Novak, S. S. Goreta, and J. Dumic, “Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells,” In Vitro Cellular Developmental Biology -Animal, vol. 48, no. 8, pp. 518–527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. B. R. Gittens, J. V. Bodkin, S. Nourshargh, M. Perretti, and D. Cooper, “Galectin-3: a positive regulator of leukocyte recruitment in the inflamed microcirculation,” The Journal of Immunology, vol. 198, no. 11, pp. 4458–4469, 2017. View at Publisher · View at Google Scholar
  7. M. Papaspyridonos, E. McNeill, J. P. de Bono et al., “Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction,” Arterioscleriosclerosis, Thrombosis and Vascular Biology, vol. 28, no. 3, pp. 433–440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Menini, C. Iacobini, C. Blasetti Fantauzzi, C. M. Pesce, and G. Pugliese, “Role of galectin-3 in obesity and impaired glucose homeostasis,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 9618092, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Wang and X. L. Guo, “Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression,” Biomedicine & Pharmacotherapy, vol. 78, pp. 165–171, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. B. S. Sumana, S. Shashidhar, and A. S. Shivarudrappa, “Galectin-3 immunohistochemical expression in thyroid neoplasms,” Journal Clinical Diagnostic Research, vol. 9, no. 11, pp. EC07–EC11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Albi, M. Krüger, R. Hemmersbach et al., “Impact of gravity on thyroid cells,” International Journal Molecular Sciences, vol. 18, no. 5, 2017. View at Publisher · View at Google Scholar
  12. E. Albi, “Role of intranuclear lipids in health and disease,” Clinical Lipidology, vol. 6, no. 1, pp. 59–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. N. C. Shah, G. J. Shah, Z. Li, X. C. Jiang, B. T. Altura, and B. M. Altura, “Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging,” International Journal of Clinical and Experimental Medicine, vol. 7, no. 3, pp. 497–514, 2014. View at Google Scholar
  14. E. Albi, F. Curcio, R. Spelat et al., “The thyroid lobes: the different twins,” Archives of Biochemistry and Biophysics, vol. 518, no. 1, pp. 16–22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Albi, S. Cataldi, G. Rossi et al., “The nuclear ceramide/diacylglycerol balance depends on the physiological state of thyroid cells and changes during UV-C radiation-induced apoptosis,” Archives of Biochemistry and Biophysics, vol. 478, no. 1, pp. 52–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Albi, S. Cataldi, A. Lazzarini et al., “Radiation and thyroid cancer,” International Journal of Molecular Sciences, vol. 18, no. 5, p. 911, 2017. View at Publisher · View at Google Scholar
  17. G. Traina, L. Menchetti, F. Rappa et al., “Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model,” The Journal of Biological Regulators and Homeostatic Agents, vol. 30, no. 3, pp. 895–901, 2016. View at Google Scholar
  18. Y. Harazono, D. H. Kho, V. Balan et al., “Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells,” Oncotarget, vol. 5, no. 20, pp. 9992–10001, 2014. View at Publisher · View at Google Scholar
  19. A. Faggiano, J. Coulot, N. Bellon et al., “Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue,” Journal Nuclear Medicine, vol. 45, no. 2, pp. 232–237, 2004. View at Google Scholar
  20. S. Sorrenti, E. Baldini, F. Tartaglia et al., “Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy,” Aging Clinical and Experimental Research, vol. 29, Supplement 1, no. S1, pp. 7–13, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Pasqualett, N. Caraccio, U. Dell Agnello, and F. Monzan, “Cognitive function and the ageing process: the peculiar role of mild thyroid failure,” Recent Patent on Endocrine Metabolic & Immune Drug Discovery, vol. 10, no. 1, pp. 4–10, 2016. View at Publisher · View at Google Scholar
  22. L. Curtò and F. Trimarchi, “Hypopituitarism in the elderly: a narrative review on clinical management of hypothalamic–pituitary–gonadal, hypothalamic–pituitary–thyroid and hypothalamic–pituitary–adrenal axes dysfunction,” Journal Endocrinological Investigation, vol. 39, no. 10, pp. 1115–1124, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Juárez-Cedillo, L. Basurto-Acevedo, S. Vega-García et al., “Prevalence of thyroid dysfunction and its impact on cognition in older mexican adults: (SADEM study),” Journal of Endocrinology Investigation, vol. 40, no. 9, pp. 945–952, 2017. View at Publisher · View at Google Scholar
  24. R. E. Mouton and M. E. Venable, “Ceramide induces expression of the senescence histochemical marker, β-galactosidase, in human fibroblasts,” Mechanisms of Ageing and Development, vol. 113, no. 3, pp. 169–181, 2000. View at Publisher · View at Google Scholar · View at Scopus